Verified Nov 2026
Batteries & E-Mobility
·

·
Since 2007
Bora Pharmaceuticals is a contract development and manufacturing organization founded in 2007 and based in Taipei, Taiwan. The company employs 1,000–5,000 staff and generates an estimated $500M–$1B in revenue. It serves automotive, electric-vehicle, medical, and industrial-equipment sectors with formulation development, cGMP manufacturing, and packaging of oral solids, liquids, semi-solids, ophthalmics, biologics, and sterile injectables. In 2026, Bora completed its U.S. manufacturing and biologics footprint and proposed a $40M expansion of its Maple Grove facility.
Bora Pharmaceuticals at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
2007
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Bora Pharmaceuticals is a contract development and manufacturing organization founded in 2007 and based in Taipei, Taiwan. The company employs 1,000–5,000 staff and generates an estimated $500M–$1B in revenue. It serves automotive, electric-vehicle, medical, and industrial-equipment sectors with formulation development, cGMP manufacturing, and packaging of oral solids, liquids, semi-solids, ophthalmics, biologics, and sterile injectables. In 2026, Bora completed its U.S. manufacturing and biologics footprint and proposed a $40M expansion of its Maple Grove facility.
At a glance
Attribute | Detail |
|---|---|
Founded | 2007 |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
Primary capability | Batteries & E-Mobility |
What Bora Pharmaceuticals makes
The company operates 10 cGMP manufacturing facilities across Asia and North America and offers end-to-end capabilities in formulation and cell-line development, analytical testing, solvent film coating, extrusion spheronization, and serialized filling and packaging.
Products and capabilities described on the company's own site include Coating (source: boracdmo.com).
Latest developments
2026-11-13 — Bora Group 3Q26: Revenue and Net Income Expansion Continues U.S. Manufacturing and Biologics Footprint Complete; Margin Expansion to Follow as Utilization Improves #BoraPharmaceuticals (media-outreach.com)
2026-09-17 — Building an integrated pharmaceutical manufacturing network - Bora Pharmaceuticals Premium CDMO (boracdmo.com)
2026-09-14 — Bora Pharmaceuticals Proposes $40M Maple Grove Facility Expansion (ccxmedia.org)
2026-09-01 — North America and Taiwan pharmaceutical manufacturing capacity update - Bora Pharmaceuticals Premium CDMO (boracdmo.com)
2026-08-31 — Transforming OSD packaging capabilities: The expansion of Bora’s Maple Grove, MN facility - Bora Pharmaceuticals Premium CDMO (boracdmo.com)
2026-05-11 — Bora Group to Acquire MacroGenics’ GMP Manufacturing Operations for $122.5M, Securing Maryland-Based Drug-Substance Facility and Existing Commercial Orders to Scale the Group’s Integrated Technology Platform - Bora Pharmaceuticals (bora-corp.com)
Facilities
Public sources reference the following locations:
Maple Grove, Minnesota — boracdmo.com
Baltimore, MD — boracdmo.com
Company details
Bora is publicly listed on the Taiwan Stock Exchange and OTCQX with a market capitalization of approximately $2.67 billion and serves over 100 markets worldwide. Bora Pharmaceuticals was founded in 2007, and has an estimated 1,000-5,000 employees.
Frequently asked questions
What does Bora Pharmaceuticals make?
Bora Pharmaceuticals is a contract development and manufacturing organization founded in 2007 and based in Taipei, Taiwan. The company employs 1,000–5,000 staff and generates an estimated $500M–$1B in revenue. It serves automotive, electric-vehicle, medical, and industrial-equipment sectors with formulation development, cGMP manufacturing, and packaging of oral solids, liquids, semi-solids, ophthalmics, biologics, and sterile injectables. In 2026, Bora completed its U.S. manufacturing and biologics footprint and proposed a $40M expansion of its Maple Grove facility.
When was Bora Pharmaceuticals founded?
Bora Pharmaceuticals was founded in 2007.
How big is Bora Pharmaceuticals?
Bora Pharmaceuticals has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
